NL
Niranjan Lal Agarwal
About Niranjan Lal Agarwal
Niranjan Lal Agarwal has 23 years in corporate governance. Holds Director role. Currently with 1 company, including Minesource India Private Limited. Formerly with 3 companies, such as Shree Sukhdham Construction Private Limited and Redrose Promoters Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Minesource India Private Limited
U51109WB2002PTC095249
|
Director | 03 Oct 2002 | 2002 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
Shree Sukhdham Construction Private Limited
U45400WB2007PTC115888
|
Director | 18 May 2007 | 2007 | Active |
Redrose Promoters Private Limited
U70109WB2011PTC161633
|
Director | 27 May 2011 | 2011 | Active |
Picasona Health Care Private Limited
U85110WB2004PTC099239
|
Director | 01 Jun 2007 | 2004 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Niranjan Lal Agarwal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Niranjan Lal Agarwal
Niranjan Lal Agarwal has 23 years in corporate governance. Holds Director role. Currently with 1 company, including Minesource India Private Limited. Formerly with 3 companies, such as Shree Sukhdham Construction Private Limited and Redrose Promoters Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations.
Niranjan Lal Agarwal is associated with 1 company as Director.
Niranjan Lal Agarwal has expertise in General Business, Healthcare.
Niranjan Lal Agarwal has 23 years in corporate governance.